• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 R 中的多步常微分方程求解算法开发用于成本效益分析的队列模拟框架。

Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in R.

机构信息

Department of Clinical Pharmacology & Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands (GWJF, JGCVH, JHMS)

Department of Pharmacy & Pharmacology, Slotervaart Hospital/Netherlands Cancer Institute, Amsterdam, The Netherlands (JGCVH, ADRH, JHMS)

出版信息

Med Decis Making. 2013 Aug;33(6):780-92. doi: 10.1177/0272989X13476763. Epub 2013 Mar 20.

DOI:10.1177/0272989X13476763
PMID:23515213
Abstract

INTRODUCTION

Dynamic processes in cost-effectiveness analysis (CEA) are typically described using cohort simulations, which can be implemented as Markov models, or alternatively using systems of ordinary differential equations (ODEs). In the field of CEA, simple and potentially inaccurate single-step algorithms are commonly used for solving ODEs, which can potentially induce bias, especially if an incorrect step size is used. The aims of this project were 1) to implement and demonstrate the use of a modern and well-established hybrid linear multistep ODE solver algorithm (LSODA) in the context of CEA using the statistical scripting language R and 2) to quantify bias in outcome for a case example CEA as generated by a commonly used single-step ODE solver algorithm.

METHODS

A previously published CEA comparing the adjuvant breast cancer therapies anastrozole and tamoxifen was used as a case example to implement the computational framework. A commonly used single-step algorithm was compared with the proposed multistep algorithm to quantify bias in the single-step method.

RESULTS

A framework implementing the multistep ODE solver LSODA was successfully developed. When a single-step ODE solver with step size of 1 year was used, incremental life-years gained was underestimated by 0.016 years (5.6% relative error, RE) and £158 (6.8% RE) compared with the multistep method.

CONCLUSION

The framework was found suitable for the conduct of CEAs. We demonstrated how the use of single-step algorithms with insufficiently small step sizes causes unnecessary bias in outcomes measures of CEAs. Scripting languages such as R can further improve transparency, reproducibility, and overall integrity in the field of health economics.

摘要

简介

成本效益分析(CEA)中的动态过程通常使用队列模拟来描述,队列模拟可以实现为马尔可夫模型,或者使用常微分方程(ODE)系统。在 CEA 领域,通常使用简单且可能不准确的单步算法来求解 ODE,这可能会导致偏差,特别是如果使用了不正确的步长。本项目的目的是 1)在 CEA 中使用统计脚本语言 R 实现和展示现代且成熟的混合线性多步 ODE 求解器算法(LSODA)的使用,并 2)量化由常用单步 ODE 求解器算法生成的 CEA 结果的偏差。

方法

使用先前发表的一项比较辅助性乳腺癌治疗药物阿那曲唑和他莫昔芬的 CEA 作为案例研究来实现计算框架。比较了常用的单步算法和提出的多步算法,以量化单步方法的偏差。

结果

成功开发了实现多步 ODE 求解器 LSODA 的框架。当使用步长为 1 年的单步 ODE 求解器时,增量生命年的估计值低估了 0.016 年(相对误差 5.6%)和 158 英镑(相对误差 6.8%),与多步方法相比。

结论

该框架适合进行 CEA。我们展示了使用步长过小的单步算法如何导致 CEA 结果测量中的不必要偏差。像 R 这样的脚本语言可以进一步提高卫生经济学领域的透明度、可重复性和整体完整性。

相似文献

1
Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in R.使用 R 中的多步常微分方程求解算法开发用于成本效益分析的队列模拟框架。
Med Decis Making. 2013 Aug;33(6):780-92. doi: 10.1177/0272989X13476763. Epub 2013 Mar 20.
2
Solving delay differential equations in S-ADAPT by method of steps.通过逐步法解决 S-ADAPT 中的时滞微分方程。
Comput Methods Programs Biomed. 2013 Sep;111(3):715-34. doi: 10.1016/j.cmpb.2013.05.026. Epub 2013 Jun 27.
3
Understanding the impact of numerical solvers on inference for differential equation models.理解数值求解器对微分方程模型推断的影响。
J R Soc Interface. 2024 Mar;21(212):20230369. doi: 10.1098/rsif.2023.0369. Epub 2024 Mar 6.
4
Numerical discretization-based estimation methods for ordinary differential equation models via penalized spline smoothing with applications in biomedical research.基于数值离散化的常微分方程模型估计方法,通过惩罚样条平滑及其在生物医学研究中的应用
Biometrics. 2012 Jun;68(2):344-52. doi: 10.1111/j.1541-0420.2012.01752.x. Epub 2012 Feb 29.
5
Combination of "quadratic adaptive algorithm" and "hybrid operator splitting" or uniformization algorithms for stability against acceleration in the Markov model of sodium ion channels in the ventricular cell model.“二次自适应算法”与“混合算子分裂”的结合或均匀化算法,用于提高心室细胞模型钠离子通道 Markov 模型中抗加速稳定性。
Med Biol Eng Comput. 2019 Jun;57(6):1367-1379. doi: 10.1007/s11517-019-01956-5. Epub 2019 Feb 23.
6
Dynamic sensitivity analysis of biological systems.生物系统的动态敏感性分析
BMC Bioinformatics. 2008 Dec 12;9 Suppl 12(Suppl 12):S17. doi: 10.1186/1471-2105-9-S12-S17.
7
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial.阿那曲唑与他莫昔芬作为绝经后早期乳腺癌女性辅助治疗的成本效益分析:美国医疗保健系统视角。ATAC(“瑞宁得”,单独使用他莫昔芬或联合使用)试验的5年完成治疗分析。
Breast Cancer Res Treat. 2007 Dec;106(2):229-38. doi: 10.1007/s10549-006-9483-6. Epub 2007 Jan 24.
8
Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.阿那曲唑与他莫昔芬用于早期乳腺癌辅助治疗的成本效益分析——基于阿那曲唑、他莫昔芬单独或联用治疗(ATAC)试验100个月分析及德国医疗体系的卫生经济学分析
Onkologie. 2010;33(4):155-66. doi: 10.1159/000286233. Epub 2010 Mar 19.
9
A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.传染病干预措施健康经济评价的动态贝叶斯马尔可夫模型。
BMC Med Res Methodol. 2018 Aug 2;18(1):82. doi: 10.1186/s12874-018-0541-7.
10
A specialized ODE integrator for the efficient computation of parameter sensitivities.一种用于高效计算参数灵敏度的专用常微分方程积分器。
BMC Syst Biol. 2012 May 20;6:46. doi: 10.1186/1752-0509-6-46.

引用本文的文献

1
A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R.一种简单的筛查成本效益模型:用R语言编写的开源教学与研究工具。
Pharmacoecon Open. 2023 Jul;7(4):507-523. doi: 10.1007/s41669-023-00414-1. Epub 2023 Jun 1.
2
An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example.使用成本效益分析示例的 R 中队列状态转换模型入门教程。
Med Decis Making. 2023 Jan;43(1):3-20. doi: 10.1177/0272989X221103163. Epub 2022 Jun 30.
3
A theoretical foundation for state-transition cohort models in health decision analysis.
健康决策分析中状态转移队列模型的理论基础。
PLoS One. 2018 Dec 11;13(12):e0205543. doi: 10.1371/journal.pone.0205543. eCollection 2018.
4
Disease Progression Modeling: Key Concepts and Recent Developments.疾病进展建模:关键概念与最新进展
Curr Pharmacol Rep. 2016 Oct;2(5):221-230. doi: 10.1007/s40495-016-0066-x. Epub 2016 Aug 15.
5
Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.卫生经济评估决策分析模型的验证:概述
Pharmacoeconomics. 2017 Jul;35(7):673-683. doi: 10.1007/s40273-017-0508-2.
6
Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial.使用多状态建模生存分析框架在R中进行成本效益分析:教程
Med Decis Making. 2017 May;37(4):340-352. doi: 10.1177/0272989X16651869. Epub 2016 Jun 8.
7
Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment With Eribulin.用于艾瑞布林治疗去势抵抗性前列腺癌的毒性、剂量强度、疾病进展及成本效益的综合模拟框架
CPT Pharmacometrics Syst Pharmacol. 2015 Jul;4(7):374-85. doi: 10.1002/psp4.48. Epub 2015 Jun 30.
8
The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance.结构性不确定性对辅助内分泌乳腺癌治疗成本效益模型的影响:需要针对特定疾病的模型标准化和改进指导。
Pharmacoeconomics. 2014 Jan;32(1):47-61. doi: 10.1007/s40273-013-0106-x.